Q2 2026 Financial Results

Solana Company generated $2.5 million in total revenue, up from just $43,000 in Q2 2025 . Nearly all of this came from staking rewards on its SOL holdings. The company achieved a gross margin of approximately 97%, with gross profit of $2.4 million . However, this top-line growth was overshadowed by a net loss of $30.3 million (or $0.38 per share), widening from a $9.8 million loss in the same quarter last year . Revenue fell short of Wall Street's $2.9 million forecast, a 13.8% miss, contributing to the same-day stock decline .

What Caused the $30.3 Million Net Loss

The net loss is primarily attributable to two large items, neither reflecting cash burn from core operations:

1. Non-cash digital asset impairment losses of $23.3 million — fair-value write-downs required under accounting rules as SOL's market price fell sharply during the quarter .
2. Net operating expenses of $35.1 million — this includes higher general & administrative costs, realized and unrealized losses on digital assets, and a one-time $6.8 million severance charge from the divestiture of the legacy PoNS medical device business .

Partially offsetting these expenses, the company recorded $2.4 million in non-operating income, including a $3.1 million gain on the sale of the PoNS business . Critically, the non-cash impairment losses do not affect the quantity of SOL tokens the company holds or its cash balances .

Staking Business Performance: Strong Operational Execution

Despite the headline loss, Solana Company's staking operations performed well:

• Staking contributed $2.512 million of total revenue, with the company earning 31,200 SOL in staking rewards during the quarter .
• The net staking yield was 6.14% APY, outperforming the Solana network average by 46 basis points .
• The company launched its first institutional validator cluster in Tokyo, securing its first institutional validator client — a key milestone in its pivot from a passive SOL holder to an active staking infrastructure provider .

Management's Steps to Fund Operations and Preserve Capital

Management took several measures to strengthen the balance sheet and fund the strategic pivot:

• Share repurchases: Executed $2.3 million in buybacks, retiring 1.3 million shares .
• Divestiture: Completed the sale of the PoNS medical device business, generating a $3.1 million gain and exiting the legacy Helius Medical line .
• Hong Kong trust acquisition: Acquired a profitable Hong Kong trust company, adding a new revenue stream and Asia-Pacific licensing capability .
• Improved MNAV ratio: The company's market-to-net-asset-value (MNAV) ratio improved from 0.73x to 0.81x, indicating slightly better market recognition of its underlying asset value .

As of June 30, 2026, Solana Company held total assets of $176.1 million, including $147.3 million in SOL tokens, giving it a substantial but volatile treasury base .

Strategic Outlook Amid SOL's 62% Decline

Solana Company is attempting to transform from a passive SOL treasury vehicle into an institutional staking infrastructure operator, but faces serious headwinds:

• Solana's 62% price decline during H1 2026 directly cratered the company's balance sheet and triggered the $23.3 million in non-cash impairment losses, exposing the core fragility of a model that depends on the token's market price .
• The strategic pivot involves becoming a validator infrastructure provider for institutions (the Tokyo cluster is the first proof point), diversifying into trust services via the Hong Kong acquisition, and reducing share count through buybacks .
• Investor skepticism remains high: The stock trades at a discount to NAV (0.81x MNAV), the revenue miss pressured shares, and the Zacks-adjusted loss of $0.05 per share was 150% worse than the consensus estimate of a $0.02 loss . For the first half of 2026, the total net loss widened to $130.1 million, largely due to $121.2 million in realized and unrealized losses on SOL holdings .

In short: Staking operations are growing fast on a small base and the company is executing its pivot, but the $30.3 million loss — driven almost entirely by SOL's 62% price collapse — underscores that Solana Company remains highly exposed to token price volatility. Until the institutional staking and trust services revenue streams are large enough to offset treasury write-downs, the company's financial health will continue to track SOL's market price.

Q2 2026 Financial Results

Solana Company generated $2.5 million in total revenue, up from just $43,000 in Q2 2025 . Nearly all of this came from staking rewards on its SOL holdings. The company achieved a gross margin of approximately 97%, with gross profit of $2.4 million . However, this top-line growth was overshadowed by a net loss of $30.3 million (or $0.38 per share), widening from a $9.8 million loss in the same quarter last year . Revenue fell short of Wall Street's $2.9 million forecast, a 13.8% miss, contributing to the same-day stock decline .

What Caused the $30.3 Million Net Loss

The net loss is primarily attributable to two large items, neither reflecting cash burn from core operations:

1. Non-cash digital asset impairment losses of $23.3 million — fair-value write-downs required under accounting rules as SOL's market price fell sharply during the quarter .
2. Net operating expenses of $35.1 million — this includes higher general & administrative costs, realized and unrealized losses on digital assets, and a one-time $6.8 million severance charge from the divestiture of the legacy PoNS medical device business .

Partially offsetting these expenses, the company recorded $2.4 million in non-operating income, including a $3.1 million gain on the sale of the PoNS business . Critically, the non-cash impairment losses do not affect the quantity of SOL tokens the company holds or its cash balances .

Staking Business Performance: Strong Operational Execution

Despite the headline loss, Solana Company's staking operations performed well:

• Staking contributed $2.512 million of total revenue, with the company earning 31,200 SOL in staking rewards during the quarter .
• The net staking yield was 6.14% APY, outperforming the Solana network average by 46 basis points .
• The company launched its first institutional validator cluster in Tokyo, securing its first institutional validator client — a key milestone in its pivot from a passive SOL holder to an active staking infrastructure provider .

Management's Steps to Fund Operations and Preserve Capital

Management took several measures to strengthen the balance sheet and fund the strategic pivot:

• Share repurchases: Executed $2.3 million in buybacks, retiring 1.3 million shares .
• Divestiture: Completed the sale of the PoNS medical device business, generating a $3.1 million gain and exiting the legacy Helius Medical line .
• Hong Kong trust acquisition: Acquired a profitable Hong Kong trust company, adding a new revenue stream and Asia-Pacific licensing capability .
• Improved MNAV ratio: The company's market-to-net-asset-value (MNAV) ratio improved from 0.73x to 0.81x, indicating slightly better market recognition of its underlying asset value .

As of June 30, 2026, Solana Company held total assets of $176.1 million, including $147.3 million in SOL tokens, giving it a substantial but volatile treasury base .

Strategic Outlook Amid SOL's 62% Decline

Solana Company is attempting to transform from a passive SOL treasury vehicle into an institutional staking infrastructure operator, but faces serious headwinds:

• Solana's 62% price decline during H1 2026 directly cratered the company's balance sheet and triggered the $23.3 million in non-cash impairment losses, exposing the core fragility of a model that depends on the token's market price .
• The strategic pivot involves becoming a validator infrastructure provider for institutions (the Tokyo cluster is the first proof point), diversifying into trust services via the Hong Kong acquisition, and reducing share count through buybacks .
• Investor skepticism remains high: The stock trades at a discount to NAV (0.81x MNAV), the revenue miss pressured shares, and the Zacks-adjusted loss of $0.05 per share was 150% worse than the consensus estimate of a $0.02 loss . For the first half of 2026, the total net loss widened to $130.1 million, largely due to $121.2 million in realized and unrealized losses on SOL holdings .

In short: Staking operations are growing fast on a small base and the company is executing its pivot, but the $30.3 million loss — driven almost entirely by SOL's 62% price collapse — underscores that Solana Company remains highly exposed to token price volatility. Until the institutional staking and trust services revenue streams are large enough to offset treasury write-downs, the company's financial health will continue to track SOL's market price.